Investors / United States / +ND Capital
+ND Capital
Venture capital · Woodside, CA, United States · North America
+ND Capital is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences. It has over $800M in assets under management across multiple funds and operates teams in Silicon Valley, Switzerland, and the Cayman Islands.
Invests inHealthcare & Biotech
In its own wordslife sciencesphysical sciencesdata sciencesdeep technanotechnology
Your fit with +ND Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fits+ND Capital lists 23 checked portfolio companies on its own site and is named in 4 funding rounds. Its most frequent entry is Series B, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (70%), AI & Machine Learning (11%) and Industrial & Manufacturing (11%). 60% of its companies are based in United States. It invests most often alongside ARCH Venture Partners, OMX Ventures and Paladin Capital Group.
Counts come from funding rounds that name +ND Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not +ND Capital's whole history. Rounds on record name 4 companies; its own site lists 23. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first round+ND Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 25% |
| Series B | 50% |
| Growth | 25% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 4 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 57th | 23 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 83th | 13% of companies confirmed by a round |
| Sector focus | 91th | 70% in its largest sector |
| Reach | 84th | 6 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| ARCH Venture Partners | 4 |
| OMX Ventures | 3 |
| Paladin Capital Group | 3 |
| 8VC | 2 |
| ATEL Ventures | 2 |
| Catalio Capital Management | 2 |
| LifeLink Ventures | 2 |
| Rheinest | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2191%
- No longer answers00%
- Points to another company29%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 70% | 15% |
| AI & Machine Learning | 11% | 18% |
| Industrial & Manufacturing | 11% | 7% |
| Robotics & Hardware | 4% | 1% |
| Food & Agriculture | 4% | 3% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with ARCH Venture Partners
Compare +ND Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with +ND Capital| Date | Company | Stage |
|---|---|---|
| 28 Sept 2026 | Series C+ | |
| 22 Sept 2026 | Series A | |
| 15 Apr 2026 | Series B | |
| 23 Mar 2026 | Series B |
Round details for +ND Capital
Amounts, full round histories and every co-investor in +ND Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
23 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Airna is developing novel medicines with the potential to deliver functional cures for patients using RNA editing technology. | Healthcare & Biotech | Portfolio page | ||
| AllIn Bio develops a precision immunology approach to treating chronic inflammatory disease | Healthcare & Biotech | Portfolio page | ||
| Amazentis develops and markets a proprietary form of Urolithin A, a postbiotic that supports mitochondrial health | Healthcare & Biotech | Portfolio page | ||
| Arc Therapeutics is a biopharmaceutical company advancing medicines for CNS patient populations | Healthcare & Biotech | Portfolio page | ||
| Constructive Bio designs and manufactures new-to-nature proteins for next-generation therapies. | Healthcare & Biotech | Portfolio page | ||
| Allegro MicroSystems is involved in Tunneling Magnetoresistance (TMR) Technology | Industrial & Manufacturing | Portfolio page | ||
| Emulate makes Organ-Chips for research and development | Healthcare & Biotech | Portfolio page | ||
| H55 builds certifiable energy storage and electric propulsion systems for the next generation of aircraft | AI & Machine LearningAI & Machine Learning | Portfolio page | ||
| Haya Therapeutics develops RNA-guided therapies to reverse disease-driving cell states and restore health. | Healthcare & Biotech | Portfolio page | ||
| The company develops a platform for single-cell functional analysis to accelerate discovery and apply novel biological insights in research and drug discovery. | Healthcare & Biotech | Apr 2026Series B | Page + round | |
| Manus Bio manufactures bioalternatives, including sweeteners and ingredients, using industrial biotechnology | Food & AgricultureIndustrial & Manufacturing | Portfolio page | ||
| Notify Therapeutics focuses on the initial ovarian follicle development to help infertile women that do not benefit from today's standard hormone treatment | Healthcare & Biotech | Portfolio page | ||
| Octant engineers biology, chemistry, and computation to develop precision medicines | Healthcare & Biotech | Portfolio page | ||
| Orca Bio is a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
| Partillion generates cell-cell interaction data for biological research and applications | Healthcare & Biotech | Portfolio page | ||
| PulseSight Therapeutics is a clinical-stage biotech company developing disruptive, non-viral gene therapies dedicated to ophthalmology | Healthcare & Biotech | Portfolio page | ||
| Ramona develops and sells live-cell imaging systems and software for research and drug screening applications | Healthcare & Biotech | Sept 2026Series A | Funding round | |
Healthcare & Biotech | Portfolio page | |||
| SiMa.ai develops and provides hardware and software for physical artificial intelligence applications | AI & Machine LearningRobotics & Hardware | Sept 2026Series C+ | Page + round | |
| SPARK Microsystems develops and provides low-power UWB wireless technology products and solutions. | Industrial & ManufacturingHealthcare & Biotech | Mar 2026Series B | Page + round |
About this data
site last read 8 Nov 2026- Site
- nd.capital
- Last read
- 8 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 23 Mar 2026
- Companies checked
- 23
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get +ND Capital's profile as data
Pull +ND Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/nd.capital
# also
GET /v1/firms/nd.capital/portfolio
GET /v1/firms/nd.capital/coinvestors
GET /v1/firms/nd.capital/news